Friday, 5 July 2013

Lume Lung 2: BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC


You must be a healthcare professional to view this section of the site. Login to view more.


share this page with othersSorry, I could not read the content fromt this page.

View the original article here

Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)